Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs

Clinical Validation of the QMAC-DST System for Testing the Drug Susceptibility of Mycobacterium tuberculosis to First- and Second-Line Drugs

There is a high demand for novel approaches to counter the various challenges of conventional drug susceptibility testing (DST) for tuberculosis, the most prevalent infectious disease with significant global mortality. The QMAC-DST system was recently developed for rapid DST using image technology t...

Full description

Bibliographic Details
Main Authors: Sangyeop Lee, Daehyun Chu, Youn Mi Choi, EunJi Jo, Suyeoun Kim, Haeun Kim, Hyun Jung Kim, Jeonghyun Chang, Heungsup Sung, Geumrae Kang, Bonghwan Jin, Eun-Geun Kim, Sunghoon Kwon, Mi-Na Kim
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-04-01
Series:Frontiers in Microbiology
Subjects:
Mycobacterium tuberculosis
drug susceptibility testing
Lowenstein-Jensen media
clinical validation
rifampin
Online Access:https://www.frontiersin.org/article/10.3389/fmicb.2019.00706/full

Internet

https://www.frontiersin.org/article/10.3389/fmicb.2019.00706/full

Similar Items